Put two packs of CBD seeds next to each other, one labelled 1:1 and the other 20:1, and the two look identical: same breeder’s packaging, the same seed count, contents that no eye can separate apart. Grow them side by side and they go their separate ways from the very first stage and never converge again. The reason is one single gene, and the easiest way to understand what it does is to follow the two packs along each stage both go through: the cross that made them, the seed, the seedling, the flowering room, the cut, the jar, the lab bench and the law. The lines used as reference points throughout are taken from the range at https://calmcbdseeds.com, and that range goes 1:1, 2:1 and 20:1 and a top line at about 30 to one; the biology holds the same whichever shop the packs came from.
Cannabis decides if it is going to make THC or CBD at one position on the genome. The gene there comes in two forms: one builds the enzyme that converts the shared precursor into THCA, the other the enzyme that converts it into CBDA. Each plant holds two copies, one received from either parent, and the pair sets the chemotype. Two THC copies make a THC-dominant plant. Two CBD copies make a CBD-dominant one. One of each gives a balanced plant, since the two versions are codominant and not one of them silences the other.
The balanced pack was made by pairing two balanced plants, both carrying one copy of each form. The 20:1 pack was bred by crossing two plants that each hold two CBD copies and no THC copy between them. That one difference at the bench decides all that follows downstream, and the difference is fully in the seed before it is packed.
Cross two balanced plants and the seeds fall themselves by the simplest rule in genetics: a quarter inherit two THC copies, a quarter get two CBD copies, half inherit one of each. In a pack of 10 seeds that works out to, on average, around two THC-dominant seeds, around two CBD-dominant ones, and five true balanced seeds. The pack is sold by its parents, and for half its seeds the label fits; in the case of the other half it is a description of something else. Calm CBD Seeds states the expected split on each balanced line, so the buyer sees ahead of sowing that a portion of the plants are going to depart from the headline ratio.
The 20:1 pack carries no such spread. Every seed received a CBD copy from each parents, each plant will be CBD-dominant, and the ratio on the foil holds to every one of them, within the small variation in how total cannabinoid an given plant produces. The trade say these lines „breed true“ for chemotype; the phrase means exactly this absence of surprise.
At this stage the two packs appear the same once more, and the likeness lasts longer than many growers expect. Chemotype shows no mark on a seedling. Leaf shape, colour, stem length and the speed of growth rate are controlled by different genes entirely, and the three kinds of plant in the balanced pack grow indistinguishably beside one another and from every plant in the 20:1 pack.
The one practical distinction during this stage arises from ancestry not chemotype. Lines with strong hemp ancestry, and that includes some less developed CBD-dominant lines, tend to stretch rangier and fill out less. A well-worked 20:1 strain behaves like a normal indoor hybrid; a young one may still shows the field in its shape. Not one of these habit says a thing about the ratio to come.
In flower the two packs start to give clues, and the majority of them point the wrong way. Trichome density is the first thing a grower judges, and it used to be a fair guide: first-generation CBD-dominant strains showed visibly less frost than their THC counterparts, a legacy from hemp. Modern selections have largely erased that gap, and a less resinous plant from the 20:1 pack can still test precisely where the foil said. Resin density and chemotype are inherited on separate genes.
Smell is an even poorer guide. The terpene profile sits on yet different genes, so the THC-dominant plant hiding in the balanced pack can smell indistinguishable to the balanced one next to it, and either can be identical to a plant from the 20:1 pack. Growers who attempt to sort a balanced pack by nose at week eight are right about half the time, which is not any better than leaving the plants unsorted at all.
At this stage the two packs diverge in a manner that benefits the grower of the 20:1 pack and also the CBD-dominant plants hidden in the balanced pack. CBDA degrades more slowly than THCA, so a CBD-dominant plant allowed a week past its peak retains most of its cannabinoid content, whereas a THC-dominant one under the same neglect has by then begun shedding THC into CBN. The cloudy rules nonetheless applies; it holds on account of the terpenes, which degrade on every plant regardless the chemotype, and a late, over-dried CBD flower tastes of little however good the lab result is.
The 20:1 pack goes into one jar. Every plant from it holds roughly the same ratio, and blending them alters nothing anyone would measuring. The balanced pack cannot be handled that way. Blend its 10 plants in a single jar and the result is a ratio that no foil ever predicted, weighted by whichever plants yielded biggest, and no later test can pull apart what went in.
The discipline that saves the grief is dull: harvest the balanced pack plant by plant, cure each separately, label them, and test each one plant at a time before anything is mixed. It is the one point in the entire process where the different chemotypes of plant in the balanced pack can still be kept apart without a laboratory, and only because each is at that moment in its own container.
Send a sample from every jar to a laboratory and the two packs at last are readable. For the 20:1 pack the certificates arrive back grouped closely near the stated ratio, differing mainly in total cannabinoid content rather than in balance. For the balanced pack they come back in three groups: a few plants showing nearly all THC, a few showing almost all CBD, and the rest sitting around one to one. Nothing of that pattern is a failure; it is the bench cross expressed as numbers.
Home test kits are sold for growers without a lab, and most show whether THC is present but not how much. That is sufficient to pull the THC-dominant jars away from a balanced pack and insufficient to assign a ratio to the rest, and that matches the most frequent need: finding out what of the 10 jars will catch out someone.
The last place at which the two packs diverge is legal, and it trips growers who assumed „CBD“ was shorthand for „hemp“. The majority of countries define hemp by a THC ceiling, a fraction of a percent of dry weight, and the exact figure varying by country and year to year. A plant from the 20:1 pack making twenty percent CBD at twenty to one also makes about one percent THC, and that is several times over the majority of limits. Certified hemp cultivars are selected to hold total cannabinoid output low so the THC fraction remains below the line at harvest; CBD seed lines are bred for rich output and allow the THC scale with it. A seller that gives only a ratio is selling a flower line; anyone who needs a legal hemp crop needs to look for a tested THC percentage at maturity and order nothing that cannot provide one.
Beyond the threshold issue, the chemotype alters nothing in the law on the seed as such. Where holding cannabis seeds is lawful and germinating them is not, the balanced pack and the 20:1 pack sit under the same position as any other pack. Where the plant is legal without restriction, the decision between them is the grower’s and nothing else’s. None of this page is legal advice, and the rule that counts is the one where the seed will be grown, rather than the one in the place it was bought.